112944-97-5

Basic information

• Product Name: 3-[(4-CHLOROBENZYL)OXY]BENZOIC ACID
• Synonyms: 3-[(4-CHLOROBENZYL)OXY]BENZOIC ACID
• CAS NO: 112944-97-5
• Molecular Formula: C₁₄H₁₁ClO₃
• Molecular Weight: 262.69
• Mol File: 112944-97-5.mol
• Article Data: 1

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3-[(4-CHLOROBENZYL)OXY]BENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[(4-CHLOROBENZYL)OXY]BENZOIC ACID(112944-97-5)
• EPA Substance Registry System: 3-[(4-CHLOROBENZYL)OXY]BENZOIC ACID(112944-97-5)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 112944-97-5(Hazardous Substances Data)

Upstream product

• 104-83-6 1-Chloro-4-(chloromethyl)benzene 
• 99-06-9 3-Carboxyphenol 
• 1329639-52-2 methyl 3-((4-chlorobenzyl)oxy)benzoate 
• 19438-10-9 methyl 3-hydroxybenzoate 

Downstream Products

• 228707-87-7 3-(4-chlorobenzyloxy)-N-(2-sulfamoylphenyl)benzamide 
• 1160260-07-0 C₁₄H₁₀Cl₂O₂ 

Relevant articles and documents

Hydrophobicity-oriented drug design (HODD) of new human 4-hydroxyphenylpyruvate dioxygenase inhibitors

Involved in the tyrosine degradation pathway, 4-hydroxyphenylpyruvate dioxygenase (HPPD) is an important target for treating type I tyrosinemia. To discover novel HPPD inhibitors, we proposed a hydrophobicity-oriented drug design (HODD) strategy based on the interactions between HPPD and the commercial drug NTBC. Most of the new compounds showed improved activity, compound d23 being the most active candidate (IC50 = 0.047 μM) with about 2-fold more potent than NTBC (IC50 = 0.085 μM). Therefore, compound d23 is a potential drug candidate to treat type I tyrosinemia.